European School of Oncology.
29 April 2023, 10:00-14:00
Tashkent, Uzbekistan
Organizers: Oncoschool by Djamila Polatova / Bureau for Cancer Research
The first International Asian (InterAsian) workshop where oncologists from various countries will discuss the importance of clinical trials and real-world data.
Program is based primarily on multidisciplinary case discussion. The task is to show that the results of clinical trials can be implemented in routine practice.
Languages: English and Russian
Republican specialized scientific practical medical
center of oncology and radiology
Address
Farobiy 383,
Olmazor district, Tashkent, Uzbekistan
(Узбекистан г. Ташкент, ул. Фароби, 383)
Registration fee
Free
Timur Mitin, M.D.
Portland, United States
Dr. Mitin is an Associate Professor of Radiation Oncology at Oregon Health and Science University in Portland, United States. He was invited to join the faculty of Harvard Medical School at the Massachusetts General Hospital, where he worked for 2 years before relocating to Oregon. Dr. Mitin is a co-author of national guidelines for management of GU malignancies written with colleagues from the American Radium Society and is an active member of ASTRO and ASCO.
Djamila Polatova, M.D.
Tashkent, Uzbekistan
Professor Djamila Polatova is the founder of “Onco school by Djamila Polatova”, head of oncology and medical radiology department of Tashkent state dental institute, General Secretary of Oncologist Association of Uzbekistan, the head of musculoskeletal tumors department of Republican scientific practical medical center of oncology and radiology. She works as orthopedic surgical oncologist and educator. Her scientific activity is dedicated to bone soft tissue and skin malignant tumors. She actively patients in educational process so that students can understand what social, legal and financial problems cancer patients face.
Ilya Tsimafeyeu, M.D.
New York/Moscow, United States/Russia
Dr. Tsimafeyeu is the founder and director of the Bureau for Cancer Research, which has been conducting numerous clinical and preclinical studies since 2007. The results of several studies were used by Eisai, OncoMax and Ruspharmtech companies to develop new products for systemic therapy. Dr. Tsimafeyeu is a Medical Oncologist, member of ASCO International Education Steering Group, and Faculty member of the College of the European School of Oncology. He is Editorial Board member of the “Kidney Cancer” (official journal of Kidney Cancer Association (USA).
Alisher Kahharov, M.D.
Tashkent, Uzbekistan
Dr. Alisher Kahharov is the associate professor of Tashkent state dental institute and vice-director of “Onco school by Djamila Polatova”. He also works as breast cancer surgical oncologist in Republican scientific practical medical center of oncology and radiology. In 2016 he made his fellowship in Inha university hospital, Republic of Korea under the mentorship of professor Young Up Cho.
Dr. Kahharov is the Ambassador of the European School of Oncology (ESO) in Uzbekistan.
- Jamshid AlimovHead, Department of Radiotherapy, Republican Medical Center of Oncology and Radiology, Tashkent, Uzbekistan
- Nana OtkhozoriaMedical Oncologist, Dept. of Medical Oncology, TODUA clinic, Tbilisi, Georgia
- Gunel MusaevaMedical Oncologist, Dept. of Medical Oncology, Azerbaijan National Cancer Center, Baku, Azerbaijan
- Samira MakhmudovaMedical Oncologist, Dept. of Medical Oncology, Azerbaijan National Cancer Center, Baku, Azerbaijan
D. Polatova - T. Mitin
I. Tsimafeyeu
11.00-11.10 Questions
11.10-11.25 Importance of Real-world data (RWD) and Real-world evidence (RWE)
T. Mitin
11.25-11.30 Questions
12.00-12.20 Break
12.20-12.50 Multidisciplinary case presentations: Lung cancer
12.50-13.20 Multidisciplinary case presentations: GI cancers
13.20-13.50 Multidisciplinary case presentations: GU tumors
13.50-14.00 Closing remarks
